<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Yonsei Med J</journal-id>
      <journal-id journal-id-type="publisher-id">YMJ</journal-id>
      <journal-title-group>
        <journal-title>Yonsei Medical Journal</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0513-5796</issn>
      <issn pub-type="epub">1976-2437</issn>
      <publisher>
        <publisher-name>Yonsei University College of Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">16642557</article-id>
      <article-id pub-id-type="pmc">2687637</article-id>
      <article-id pub-id-type="doi">10.3349/ymj.2006.47.2.255</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A Case Report of Familial Benign Hypocalciuric Hypercalcemia: A Mutation in the Calcium-Sensing Receptor Gene</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Woo</surname>
            <given-names>Seong Ill</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Song</surname>
            <given-names>Hyunju</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Song</surname>
            <given-names>Kyung Eun</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Dae Jung</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Kwan Woo</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Se Joong</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Chung</surname>
            <given-names>Yoon-Sok</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Urology, Ajou University School of Medicine, Suwon, Korea.</aff>
      <author-notes>
        <corresp>
Reprint address: requests to Dr. Yoon-Sok Chung, Department of Endocrinology and Metabolism, Ajou University School of Medicine, 5 Wonchon-dong Yeongtong-gu, Suwon 443-721, Korea, Tel: 82-31-219-5127, Fax: 82-31-219-4497, <email>yschung@ajou.ac.kr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>30</day>
        <month>4</month>
        <year>2006</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>30</day>
        <month>4</month>
        <year>2006</year>
      </pub-date>
      <volume>47</volume>
      <issue>2</issue>
      <fpage>255</fpage>
      <lpage>258</lpage>
      <history>
        <date date-type="received">
          <day>07</day>
          <month>7</month>
          <year>2004</year>
        </date>
        <date date-type="accepted">
          <day>26</day>
          <month>11</month>
          <year>2004</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2006 The Yonsei University College of Medicine</copyright-statement>
        <copyright-year>2006</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Familial benign hypocalciuric hypercalcemia (FBHH) is an autosomal dominant trait with high penetrance, clinically manifestating a relatively benign, lifelong, persistent hypercalcemia and hypocalciuria without hypercalcemic related complications. The calcium-sensing receptor (CaSR) plays an important role in the regulation of PTH secretion and calcium metabolism. Here we present a family with FBHH of an autosomal dominant inheritance. A heterozygous mutation of E297K (GAG&#x2192;AAG, exon 4) of CaSR gene was found in 3 family members. To our knowledge, it is the first confirmed case of FBHH with CaSR gene mutation in Korea.</p>
      </abstract>
      <kwd-group>
        <kwd>Autosomal dominant</kwd>
        <kwd>familial</kwd>
        <kwd>hypocalciuric hypercalcemia</kwd>
        <kwd>calcium-sensing receptor mutation</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Familial benign hypocalciuric hypercalcemia (FBHH) is a rare autosomal dominant disorder exhibiting benign hypercalcemia, inappropriately normal parathyroid hormone (PTH) levels and relative hypocalciuria, thus reflecting partial resistance to the normal effects of extracellular calcium on parathyroid glands and kidneys.<xref ref-type="bibr" rid="B1">1</xref> The CaSR is expressed abundantly in the parathyroid gland, thyroid C cells, and kidney. The vast majority of FBHH kindred's have their genetic abnormality link to chromosome 3q21-24, the locus for the CaSR gene.<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref> We report a Korean family with FBHH carrying a mutation in the CaSR gene.</p>
    </sec>
    <sec sec-type="cases">
      <title>CASE REPORT</title>
      <p>A 38-year-old male admitted to the hospital because of a known 3 cm sized right renal mass detected by abdominal ultrasonography in routine health check up and confirmed by computed tomography. He underwent right radical nephrectomy and the pathologic report revealed clear cell type renal cell carcinoma with capsular invasion, but without distant metastasis. His serum calcium level was 10.9 mg/dL (normal, 8.8-10.8) at preoperative evaluation but was ignored. One year after surgery for a follow-up visit, he was referred to the Endocrinology and Metabolism department due to persistent hypercalcemia. The serum calcium level was 11.1 mg/dL and the inorganic phosphorus was 3.5 mg/dL (normal, 2.5-4.5). The serum alkaline phosphatase level was 67 U/L (normal, 30-120), intact PTH was 32 pg/mL (normal, 10-65), and urine calcium was 20 mg/day (normal, 100-300). A ratio of urine calcium creatinine clearance was 0.0019. Thyroid and adrenal hormone levels were normal. There was no evidence of local recurrence or metastasis of carcinoma. The bone mineral density of the femoral neck and lumbar spines performed by dual energy x-ray absorptiometry (Expert XL, Lunar Co., Madison, WI, USA) showed normal (femoral neck T-score, 1.0; lumbar spines T-score, -0.6). The biochemical and clinical evaluation was consistent with FBHH.</p>
      <p>Genomic DNA was isolated from whole blood samples using QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany) after informed consent was obtained. DNA sequence of CaSR gene of the proband was analyzed by PCR amplification of all coding exons of CaSR gene and direct sequencing of PCR products. Briefly, the PCR amplification was carried out in a PTC-225 DNA Engine Tetrad (MJ Research, Waltham, MA, USA). PCR condition was 94&#x2103; for 5 minutes for 1 cycle, and 94&#x2103; for 45s, 60&#x2103; for 45s, 72&#x2103; for 120s for 30 cycles and 72&#x2103; for 5 minutes for 1 cycle using Taq DNA polymerase (SolGent Co. Daejeon, South Korea). All of the coding exons (exon 2-exon 7) were analyzed by direct sequencing of PCR products using an ABI PRISM BigDye kit from Applied Biosystems. Forward and reverse sequences of PCR products were produced with an ABI PRISM 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA).</p>
      <p>The result revealed that the proband had a heterozygous mutation of E297K (GAG&#x2192;AAG, Glu&#x2192;Lys, nucleotide 889 G A, exon 4) of CaSR gene (<xref ref-type="fig" rid="F1">Fig. 1</xref>). The 74bp PCR product including <italic>Mnl</italic> I site was amplified using the primers CaSR_RFLP_F (CTCATCAAGGAGATTGTCCGG) and CaSR_RFLP_R (GAGGAGCTGGCCCAGGC). PCR amplification was carried out employing the same method mentioned above. The product of PCR amplification was digested with 1ul (5U) of Mnl I enzyme. The digestion occurred for 2 hours at 37&#x2103;, which was then electrophoretically resolved in components 2.5% agarose gel in 0.5X TBE. The result revealed that the proband had a heterozygous loss of an Mnl I site (<xref ref-type="fig" rid="F2">Fig. 2</xref>).</p>
      <p>We performed biochemical and clinical evaluation of his family members. The plasma calcium of his 8-year-old son revealed 10.7 mg/dL, the inorganic phosphorus was 4.2 mg/dL and PTH was 56 pg/mL and random urine calcium 1.9 mg/dl, urine creatinine 82.0 mg/dL, the ratio of urine calcium creatinine clearance was 0.0013. The same mutation of codon 297 was found in his son and his 66-year-old mother. Biochemical and genetic analysis of his daughter and sister were normal (<xref ref-type="fig" rid="F3">Fig. 3</xref>).</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>FBHH is a hypercalcemic syndrome usually characterized by as an asymptomatic and uncomplicated hypercalcemia and apparent normal longevity. The mode of inheritance is autosomal dominant with high penetrance, affecting both genders equally. The hypercalcemia is usually diagnosed at a young age, and it could be diagnosed as early as birth if screened for.<xref ref-type="bibr" rid="B4">4</xref></p>
      <p>FBHH is a rare disorder, but it is clinically important because it can be confused with primary hyperparathyroidism. The biochemical features of the two conditions are similar, but the former is benign while the latter can have serious clinical consequences with patients occasionally proceeding to parathyroidectomy.</p>
      <p>The serum calcium level (total and ionized) is usually mildly elevated; values are indistinguishable from those of patients with primary hyperparathyroidism. Similar to hyperparathyroidism, serum phosphate levels are normal to slightly decreased, but serum magnesium levels are normal to slightly elevated.<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B7">7</xref> Abnormal calcium-sensing in FBHH is reflected in the inappropriately normal parathyroid hormone (PTH) levels in the overwhelming majority of patients with FBHH, whereas over 85% of patients with hyperparathyroidism have elevated PTH levels.<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref> In FBHH, 1,25-dihydroxyvitamin D levels have been reported to be normal.<xref ref-type="bibr" rid="B5">5</xref> Urinary indices usually reveal relative hypocalciuria for the degree of hypercalcemia, pointing to excessively avid tubular renal calcium reabsorption.<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B10">10</xref> A calcium creatinine clearance ratio ([UCa &#xD7; SCr]/[SCa &#xD7; UCr]) below 0.01 has been suggested as cut-off values in patients with FBHH in the absence of other factors lowering urinary calcium excretion, whereas a ratio over 0.02 as with hyperparathyroidism.<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B10">10</xref> Kidney function, is normal, as well as urinary concentrating ability, in contrast to hyperparathyroidism.<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B11">11</xref></p>
      <p>The calcium-sensing receptor (CaSR) is a cell surface protein that consists of 1078 amino acids and belongs to the superfamily of the seven-transmembrane domain, G protein coupled receptors.<xref ref-type="bibr" rid="B2">2</xref> Over 90% of FBHH kindred's have their genetic abnormality linked to chromosome 3q21 - 24, the locus for the CaSR gene.<xref ref-type="bibr" rid="B3">3</xref> Most mutations in the CaSR associated with FBHH are single point mutations (inactivating mutation) localized in either the region encoding the extracellular calcium-sensing domain, particularly exon 3 and 4, or the region encoding the signal-transducing domain, exon.<xref ref-type="bibr" rid="B7">7</xref></p>
      <p>Renal cell carcinoma often shows hypercalcemia, so we evaluated the relationship between renal cell carcinoma and hypercalcemia in this case. The radiologic findings revealed no evidence of distant metastasis including bone or local recurrence. The laboratory findings of the patient were not relevant to those in the case of malignancy due to elevation of PTHrP, such as hypercalcemia, hypophosphatemia, hypercalciuria, and decreased levels of parathyroid hormone. Von Hippel Lindau disease (VHL) is an autosomal dominant familial cancer syndrome.<xref ref-type="bibr" rid="B12">12</xref> Affected patients are predisposed to develop central nervous system hemangioblastomas, renal cell carcinoma, and pheochromocytoma.<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref> To determine if a relationship existed between FBHH in this case and VHL, we analyzed the pedigree and chromosomes of the family and searched for any existing organ involvement. The findings demonstrated that there was no relationship between FBHH and renal cell carcinoma or between FBHH and VHL in this case.</p>
      <p>Currently, more than 40 inactivating mutations in the CaSR gene have been identified in patients with FBHH.<xref ref-type="bibr" rid="B14">14</xref>-<xref ref-type="bibr" rid="B18">18</xref> We report here a Korean family with FBHH carrying a mutation in the CaSR gene. The mutation was located in extracellular domain of CaSR as E297K mutation, which was already reported by Pollak et al. in 1993.<xref ref-type="bibr" rid="B2">2</xref> The prevalence of E297K mutation is not reported, and this is actually the second case in English literature. The prevalence of CaSR gene mutation associated with FBHH is even largely unknown, but is estimated at 1 of 78,000, at least in Scotland.<xref ref-type="bibr" rid="B19">19</xref></p>
      <p>The mechanism of CaSR insensitivity by E297K heterozygous mutation was studied in human embryonic kidney cells. The E297K mutation leads to formation of heterodimers of CaSR compared to wild type homodimerization. As a result, extracellular calcium-elicited increase in cytosolic calcium is impaired about 63%.<xref ref-type="bibr" rid="B20">20</xref> To our knowledge, it is the first case of FBHH confirmed with CaSR gene mutation in Korea, and the second case of E297K mutation in English literature.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fuleihan</surname>
              <given-names>Gel-H</given-names>
            </name>
          </person-group>
          <article-title>Familial benign hypocalciuric hypercalcemia</article-title>
          <source>J Bone Miner Res</source>
          <year>2002</year>
          <volume>17</volume>
          <issue>Suppl 2</issue>
          <fpage>N51</fpage>
          <lpage>N56</lpage>
          <pub-id pub-id-type="pmid">12412778</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pollak</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Chou</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Hebert</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Marx</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Steinmann</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutations in the human Ca<sup>2+</sup>-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism</article-title>
          <source>Cell</source>
          <year>1993</year>
          <volume>75</volume>
          <fpage>1297</fpage>
          <lpage>1303</lpage>
          <pub-id pub-id-type="pmid">7916660</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chou</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Levi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Crowe</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Atkinson</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Arnqvist</surname>
              <given-names>HJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The gene responsible for familial hypocalciuric hypercalcemia maps to chromosome 3q in four unrelated families</article-title>
          <source>Nat Genet</source>
          <year>1992</year>
          <volume>1</volume>
          <fpage>295</fpage>
          <lpage>300</lpage>
          <pub-id pub-id-type="pmid">1302026</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marx</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Attie</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Levine</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Spiegel</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Downs</surname>
              <given-names>RW</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Lasker</surname>
              <given-names>RD</given-names>
            </name>
          </person-group>
          <article-title>The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds</article-title>
          <source>Medicine (Baltimore)</source>
          <year>1981</year>
          <volume>60</volume>
          <fpage>397</fpage>
          <lpage>412</lpage>
          <pub-id pub-id-type="pmid">7311809</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Law</surname>
              <given-names>WM</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Heath</surname>
              <given-names>H</given-names>
              <suffix>3rd</suffix>
            </name>
          </person-group>
          <article-title>Familial benign hypercalcemia (hypocalciuric hypercalcemia). Clinical and pathogenetic studies in 21 families</article-title>
          <source>Ann Intern Med</source>
          <year>1985</year>
          <volume>102</volume>
          <fpage>511</fpage>
          <lpage>519</lpage>
          <pub-id pub-id-type="pmid">3977197</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rajala</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Heath</surname>
              <given-names>H</given-names>
              <suffix>3rd</suffix>
            </name>
          </person-group>
          <article-title>Distribution of serum calcium values in patients with familial benign hypercalcemia (hypocalciuric hypercalcemia): evidence for a discrete defect</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>1987</year>
          <volume>65</volume>
          <fpage>1039</fpage>
          <lpage>1041</lpage>
          <pub-id pub-id-type="pmid">3667874</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marx</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Spiegel</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Koelhler</surname>
              <given-names>JO</given-names>
            </name>
            <name>
              <surname>Gardner</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Brennan</surname>
              <given-names>MF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Divalent cation metabolism. Familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism</article-title>
          <source>Am J Med</source>
          <year>1978</year>
          <volume>65</volume>
          <fpage>235</fpage>
          <lpage>242</lpage>
          <pub-id pub-id-type="pmid">686009</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Firek</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Kao</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Heath</surname>
              <given-names>H</given-names>
              <suffix>3rd</suffix>
            </name>
          </person-group>
          <article-title>Plasma intact parathyroid hormone (PTH) and PTH-related peptide in familial benign hypercalcemia: greater responsiveness to endogenous PTH than in primary hyperparathyroidism</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>1991</year>
          <volume>72</volume>
          <fpage>541</fpage>
          <lpage>546</lpage>
          <pub-id pub-id-type="pmid">1997510</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rajala</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Klee</surname>
              <given-names>GG</given-names>
            </name>
            <name>
              <surname>Heath</surname>
              <given-names>H</given-names>
              <suffix>3rd</suffix>
            </name>
          </person-group>
          <article-title>Calcium regulation of parathyroid and C cell function in familial benign hypercalcemia</article-title>
          <source>J Bone Miner Res</source>
          <year>1991</year>
          <volume>6</volume>
          <fpage>117</fpage>
          <lpage>124</lpage>
          <pub-id pub-id-type="pmid">2028833</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stuckey</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Kent</surname>
              <given-names>GN</given-names>
            </name>
            <name>
              <surname>Gutteridge</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Pullan</surname>
              <given-names>PT</given-names>
            </name>
            <name>
              <surname>Price</surname>
              <given-names>RI</given-names>
            </name>
            <name>
              <surname>Bhagat</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Fasting calcium excretion and parathyroid hormone together distinguish familial hypocalciuric hypercalcemia from primary hyperparathyroidism</article-title>
          <source>Clin Endocrinol (Oxf)</source>
          <year>1987</year>
          <volume>27</volume>
          <fpage>525</fpage>
          <lpage>533</lpage>
          <pub-id pub-id-type="pmid">3450451</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marx</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Attie</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Stock</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Speigel</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Levine</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Maximal urine-concentrating ability: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>1981</year>
          <volume>52</volume>
          <fpage>736</fpage>
          <lpage>740</lpage>
          <pub-id pub-id-type="pmid">6259192</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Friedrich</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>Von Hippel-Lindau syndrome. A pleomorphic condition</article-title>
          <source>Cancer</source>
          <year>1999</year>
          <volume>86</volume>
          <issue>11</issue>
          <supplement>Suppl</supplement>
          <fpage>2478</fpage>
          <lpage>2482</lpage>
          <pub-id pub-id-type="pmid">10630173</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pavlovich</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>The genetic basis of renal cell carcinoma</article-title>
          <source>Urol Clin North Am</source>
          <year>2003</year>
          <volume>30</volume>
          <fpage>437</fpage>
          <lpage>454</lpage>
          <pub-id pub-id-type="pmid">12953747</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Houache</surname>
              <given-names>OM</given-names>
            </name>
          </person-group>
          <article-title>Extracellular calcium-sensing receptor: structural and functional features and association with diseases</article-title>
          <source>Braz J Med Biol Res</source>
          <year>2001</year>
          <volume>34</volume>
          <fpage>577</fpage>
          <lpage>584</lpage>
          <pub-id pub-id-type="pmid">11323743</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pidasheva</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>D'Souza-Li</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Canaff</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Cole</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Hendy</surname>
              <given-names>GN</given-names>
            </name>
          </person-group>
          <article-title>CASRdb: calcium-sensing receptor locus-specific database for mutations causing familial (benign) hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia</article-title>
          <source>Hum Mutat</source>
          <year>2004</year>
          <volume>24</volume>
          <fpage>107</fpage>
          <lpage>111</lpage>
          <pub-id pub-id-type="pmid">15241791</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thakker</surname>
              <given-names>RV</given-names>
            </name>
          </person-group>
          <article-title>Diseases associated with the extracellular calcium-sensing receptor</article-title>
          <source>Cell Calcium</source>
          <year>2004</year>
          <volume>35</volume>
          <fpage>275</fpage>
          <lpage>282</lpage>
          <pub-id pub-id-type="pmid">15200151</pub-id>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pearce</surname>
              <given-names>SH</given-names>
            </name>
          </person-group>
          <article-title>Clinical disorders of extracellular calcium-sensing and the molecular biology of the calcium-sensing receptor</article-title>
          <source>Ann Med</source>
          <year>2002</year>
          <volume>34</volume>
          <fpage>201</fpage>
          <lpage>206</lpage>
          <pub-id pub-id-type="pmid">12173690</pub-id>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Spiegel</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>Naturally occurring mutations of the extracellular Ca2+-sensing receptor: implications for its structure and function</article-title>
          <source>Trends Endocrinol Metab</source>
          <year>2003</year>
          <volume>14</volume>
          <fpage>282</fpage>
          <lpage>288</lpage>
          <pub-id pub-id-type="pmid">12890593</pub-id>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hinnie</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bell</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>McKillop</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Gallacher</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>The prevalence of familial hypocalciuric hypercalcemia</article-title>
          <source>Calcif Tissue Int</source>
          <year>2001</year>
          <volume>68</volume>
          <fpage>216</fpage>
          <lpage>218</lpage>
          <pub-id pub-id-type="pmid">11353947</pub-id>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bai</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Trivedi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kifor</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Quinn</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
          <article-title>Intermolecular interactions between dimeric calcium-sensing receptor monomers are important for its normal function</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1999</year>
          <volume>96</volume>
          <fpage>2834</fpage>
          <lpage>2839</lpage>
          <pub-id pub-id-type="pmid">10077597</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" position="float">
      <label>Fig. 1</label>
      <caption>
        <p>The direct sequencing analysis of PCR products of the proband. The result revealed a heterozygous mutation of E297K (GAG&#x2192;AAG, exon 4) of CaSR gene.</p>
      </caption>
      <graphic xlink:href="ymj-47-255-g001"/>
    </fig>
    <fig id="F2" position="float">
      <label>Fig. 2</label>
      <caption>
        <p><italic>Mnl</italic> I restriction digest of PCR-amplified DNA from 5 family members. The individual with FBHH exhibits heterozygous loss of an <italic>Mnl</italic> I site, resulting in the appearance of 74bp fragment derived from the mutant allele, and 47bp + 27bp fragment derived from the normal allele.</p>
      </caption>
      <graphic xlink:href="ymj-47-255-g002"/>
    </fig>
    <fig id="F3" position="float">
      <label>Fig. 3</label>
      <caption>
        <p>Pedigree of the FBHH family. Circles indicate women, squares indicate men, and arrow indicates the proband. Hatched symbols represent individuals with heterozygous E297K mutation.</p>
      </caption>
      <graphic xlink:href="ymj-47-255-g003"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
